Ahmed Abdel-Latif

Associate Professor

University of Kentucky

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Ahmed Abdel-Latif is an Associate Professor at the University of Kentucky, USA. His research primarily focuses on cardiovascular diseases, including myocardial infarction and ischemic cardiomyopathy, with recent publications exploring topics such as epigenetic modifications and the role of immune cells in cardiovascular inflammation. Additionally, he investigates innovative therapeutic approaches, including stem cell-based therapies and their applications in conditions like COVID-19.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Congqing Wu

Assistant Professor

University of Kentucky

UNITED STATES

View details

Ahmed Lotfy

Medical University of South Carolina

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ahmed Abdel-Latif

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Autotaxin Inhibition Reduces Post‐Ischemic Myocardial Inflammation via Epigenetic Gene Modifications

Prognostic Significance of Activated Monocytes in Patients with ST-Elevation Myocardial Infarction

Autologous CD133 + Cells and Laser Revascularization in patients with severe Ischemic Cardiomyopathy

Combined Transplantation of Human MSCs and ECFCs Improves Cardiac Function and Decrease Cardiomyocyte Apoptosis After Acute Myocardial Infarction

Myeloid-Specific Deletion of Lipid Plpp3 (Phosphate Phosphatase 3) Increases Cardiac Inflammation After Myocardial Infarction

Mesenchymal stromal cells coated with anti-ACE2 antibodies might improve efficacy against COVID-19

Cangrelor in addition to standard therapy reduces cardiac damage and inflammatory markers in patients with ST-segment elevation myocardial infarction

A Novel Role of Claudin-5 in Prevention of Mitochondrial Fission Against Ischemic/Hypoxic Stress in Cardiomyocytes

Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects

Inflammasome activation promotes venous thrombosis through pyroptosis

Comparative Effectiveness of Anti-Inflammatory Drug Treatments in Coronary Heart Disease Patients: A Systematic Review and Network Meta-Analysis

Collaborators (2)

Congqing Wu

Ahmed Lotfy

Make your next move.